2013
Boston Scientific doubles Q4 earnings
Boston Scientific (NYSE:BSX) doubled its earnings per share during the 4th quarter on an 80% profit surge eked out despite flat sales growth that still topped analysts’ expectations.
Align Technology beats The Street with tripled Q4 profits
California’s Align Technology (NSDQ:ALGN) posted some very strong numbers for its 4th quarter, boosting full-year figures beyond Wall Street’s expectations.
Legal win, buyouts boost Bard’s bottom line
A nearly $900 million award from W.L. Gore boosted C.R. Bard’s bottom line in Q4 as sales inch up 3% in 2013: Officials announce $500 million share buyback plan.
Cardiovascular Systems surges on Q2 results, outlook
Cardiovascular Systems (NSDQ:CSII) shares surged nearly 20% today on better-than-expected fiscal 2nd-quarter numbers and a 3rd-quarter outlook that came out well ahead of Wall Street’s forecast.
Zimmer’s Q4 profits surge
Philips Healthcare’s Q4, 2013 profits rise despite lower sales
Philips Healthcare (NYSE:PHG) saw its profits rise at significant double-digit clip during the 4th quarter and 2013, despite declining sales.
SpineVision posts 27% sales boost in 2013
French spinal surgery devices maker SpineVision posted a strong fiscal 2013, with a doubling in product sales due in part to impressive growth in the U.S.
SpineVision reported doubled U.S. sales of its U.L.I.S. universal pedicle anchorage screws and LUMIS minimally invasive lumbar system.
ResMed slumps on disappointing U.S. sales and missed Q2 earnings
Intuitive Surgical loses points after-hours after posting 2013 earnings
Sunnyvale, Calif.-based surgical robotics maker Intuitive Surgical (NSDQ:ISRG) lost a little Wall Street love today after the company reported 4th quarter and fiscal 2013 financial figures.